Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8+ T Cell Function via l-Arginine Metabolism
- 1 April 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (7), 3086-3094
- https://doi.org/10.1158/0008-5472.can-08-2826
Abstract
Dendritic cells (DC) have a critical effect on the outcome of adaptive immune responses against growing tumors. Whereas it is generally assumed that the presence of phenotypically mature DCs should promote protective antitumor immunity, evidence to the contrary does exist. We describe here a novel mechanism by which tumor-infiltrating dendritic cells (TIDC) actively contribute to the suppression of protective CD8+ T-cell–based antitumor immunity. Using the BALB/NeuT model of spontaneously arising mammary carcinoma, we found that canonical MHC II+/CD11b+/CD11chigh TIDCs act as regulatory DCs to suppress CD8+ T-cell function, resulting in diminished T-cell–based antitumor immunity in vivo. Stimulation of naive T cells with regulatory TIDCs resulted in an altered cell fate program characterized by minimal T-cell expansion, impaired IFNγ production, and anergy. Suppression by regulatory TIDCs overcame stimulatory signals provided by standard DCs, occurred in the absence of cognate interactions with T cells, and was mediated primarily by arginase metabolism of l-arginine. Immunosuppressive TIDCs were found in every murine tumor type examined and were phenotypically distinct from tumor-infiltrating CD11cint-low/CD11b+/Gr-1+ myeloid-derived suppressor cells. Thus, within the tumor microenvironment, MHC II+ TIDCs can function as potent suppressors of CD8+ T-cell immunity. [Cancer Res 2009;69(7):3086–94]Keywords
Other Versions
This publication has 46 references indexed in Scilit:
- The role of myeloid cells in the promotion of tumour angiogenesisNature Reviews Cancer, 2008
- Adaptive immunity maintains occult cancer in an equilibrium stateNature, 2007
- Disruption of E-Cadherin-Mediated Adhesion Induces a Functionally Distinct Pathway of Dendritic Cell MaturationImmunity, 2007
- Rapid Maturation of Effector T Cells in Tumors, but Not Lymphoid Organs, during Tumor RegressionPLOS ONE, 2007
- Altered macrophage differentiation and immune dysfunction in tumor developmentJCI Insight, 2007
- DC-based cancer vaccinesJCI Insight, 2007
- Breast cancer instructs dendritic cells to prime interleukin 13–secreting CD4+ T cells that facilitate tumor developmentThe Journal of Experimental Medicine, 2007
- Immunosuppressive Strategies that are Mediated by Tumor CellsAnnual Review of Immunology, 2007
- A feedback transcriptional mechanism controls the level of the arginine/lysine transporter cat-1 during amino acid starvationBiochemical Journal, 2007
- l-arginine availability regulates T-lymphocyte cell-cycle progressionBlood, 2006